Search Results - "Balbino, Jaime Espin"

Refine Results
  1. 1

    Mapping capacity to conduct health technology assessment in Central, Eastern and South-Eastern Europe by de Labry Lima, Antonio Olry, Mochon, Leticia García, Martínez, Araceli Caro, Ruiz, Eva Martín, Balbino, Jaime Espin

    Published in Croatian medical journal (01-02-2016)
    “…To provide insights into the capacity to conduct health technology assessment (HTA) in Central, Eastern, and South-Eastern Europe (CESEE), taking account of…”
    Get full text
    Journal Article Paper
  2. 2

    A comparison of the accuracy of liquid cytology versus conventional screening: a meta-analysis of split-sample studies by Epstein, David, de Labry Lima, Antonio Olry, Mochón, Leticia García, Balbino, Jaime Espín, Esquivias, Javier

    “…The aim of the paper is to compare the accuracy and effectiveness of liquid-based versus conventional cytology when used as part of a process of population…”
    Get full text
    Journal Article
  3. 3

    Competition in the off-patent medicine market in Spain: The national reference pricing system versus the regional system of tendering for outpatient prescription medicines in Andalusia by Casanova-Juanes, Julieta, Mestre-Ferrandiz, Jorge, Espín-Balbino, Jaime

    Published in Health policy (Amsterdam) (01-12-2018)
    “…•Andalusia is using regional tenders to procure off-patent, outpatient prescription medicines.•These tenders procure off patent medicines dispensed in primary…”
    Get full text
    Journal Article
  4. 4

    HTA and decision-making processes in Central, Eastern and South Eastern Europe: Results from a survey by García-Mochón, Leticia, Espín Balbino, Jaime, Olry de Labry Lima, Antonio, Caro Martinez, Araceli, Martin Ruiz, Eva, Pérez Velasco, Román

    Published in Health policy (Amsterdam) (01-02-2019)
    “…Highlights • High level of heterogeneity in development of HTA structures, methods and processes.. • Differences related to politicized decision-making,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Controversial Issues in Economic Evaluation (II): health Outcomes of Health Care Interventions by Trapero-Bertran, Marta, Brosa Riestra, Max, Espín Balbino, Jaime, Oliva, Juan

    Published in Revista espanola de salud publica (01-04-2015)
    “…In this second article of a series of three, we will discuss using the Metaplan technique on controversial issues of health outcomes in economic evaluation of…”
    Get more information
    Journal Article
  7. 7

    Controversial Issues in Economic Evaluation (III): health Care Interventions in Special Situations by Espín Balbino, Jaime, Brosa Riestra, Max, Oliva Moreno, Juan, Trapero-Bertran, Marta

    Published in Revista espanola de salud publica (01-05-2015)
    “…The development of the economic evaluation of health care interventions has become a support tool in making decisions on pricing and reimbursement of new…”
    Get more information
    Journal Article
  8. 8

    Adoption of the HPV vaccine: a case study of three emerging countries by Caro Martínez, Araceli, Espín Balbino, Jaime, Lemgruber, Alexandre, Martín Ruiz, Eva, Olry de Labry Lima, Antonio, García-Mochón, Leticia, Lessa, Fernanda

    “…The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries, due to its potential to reduce the impact of…”
    Get full text
    Journal Article
  9. 9

    Health technology assessment process of a cardiovascular medical device in four different settings by Olry de Labry Lima, Antonio, Espín Balbino, Jaime, Lemgruber, Alexandre, Caro Martínez, Araceli, García-Mochón, Leticia, Martín Ruiz, Eva, Lessa, Fernanda

    “…Health technology assessment (HTA) is a tool to help the decision-making process. The aim is to describe methods and processes used in the reimbursement…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Systematic review of economic evaluation studies and budget impact on ambulatory monitoring of capillary glucose in type 2 diabetics by Olry de Labry Lima, Antonio, Moya Garrido, María Natividad, Espín Balbino, Jaime

    Published in Primary care diabetes (01-04-2014)
    “…Abstract Objective Realise a review of studies of economic evaluation about the ambulatory monitoring of capillary glucose (AMGC) in diabetic type II persons…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cuestiones controvertidas en evaluación económica (II): medidas de resultado en salud de las intervenciones sanitarias by Trapero-Bertran, Marta, Brosa Riestra, Max, Espín Balbino, Jaime, Oliva, Juan

    Published in Revista española de salud pública (01-04-2015)
    “…In this second article of a series of three, we will discuss using the Metaplan technique on controversial issues of health outcomes in economic evaluation of…”
    Get full text
    Journal Article
  14. 14

    Adoption of the HPV vaccine: a case study of three emerging countries by Caro Martínez, Araceli, Espín Balbino, Jaime, Lemgruber, Alexandre, Martín Ruiz, Eva, Olry de Labry Lima, Antonio, García-Mochón, Leticia, Lessa, Fernanda

    “…The human papillomavirus (HPV) vaccine has recently attracted considerable attention in emerging countries, due to its potential to reduce the impact of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España by Rafael Ruiz-Montero, David Epstein, Bernardo Guzmán Herrador, Jaime Espín Balbino

    Published in Gaceta sanitaria (01-07-2020)
    “…Resumen: Introducción: Bexsero® (4CMenB), vacuna contra el meningococo B, fue autorizada en Europa en 2013. En España, a pesar de que el meningococo B es la…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España by Ruiz-Montero, Rafael, Epstein, David, Guzmán Herrador, Bernardo, Espín Balbino, Jaime

    Published in Gaceta sanitaria (01-08-2020)
    “…Resumen Introducción Bexsero® (4CMenB), vacuna contra el meningococo B, fue autorizada en Europa en 2013. En España, a pesar de que el meningococo B es la…”
    Get full text
    Journal Article
  19. 19

    Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España by Ruiz-Montero, Rafael, Epstein, David, Guzmán Herrador, Bernardo, Espín Balbino, Jaime

    Published in Gaceta sanitaria (01-07-2020)
    “…Bexsero® (4CMenB), vacuna contra el meningococo B, fue autorizada en Europa en 2013. En España, a pesar de que el meningococo B es la principal causa de…”
    Get full text
    Journal Article
  20. 20